On June 16, 2026, U.S. District Judge Gregory B. Williams of the United States District Court for the District of
Continue Reading mRNA Patent Wars Update: Delaware Court Allows Moderna and Pfizer/BioNTech to Assert Laches in GSK Patent Infringement Cases
Targeted protein degradation (TPD) has moved from promising concept to near-commercial reality in under a decade. By hijacking the cell’s
Continue Reading Target Acquired, Protein Deleted: The Next Frontier in Precision Medicine and IP Strategy – March 2026 Update
On February 2, 2026, U.S. District Court for the Eastern District of Pennsylvania Judge Joshua D. Wolson, sitting by designation
Continue Reading Judge Wolson Issues Key Summary Judgment Ruling on the Eve of Trial in the Arbutus v. Moderna mRNA Vaccine and Lipid Nanoparticle Case
Background
Artificial Intelligence (“AI”) has been utilized by innovative companies across the array of industry spaces, but its impact on
Continue Reading Key IP Licensing Considerations for AI Drug Discovery Platforms
Targeted protein degradation (TPD) is transforming drug discovery by leveraging the cell’s natural
Continue Reading Target Acquired, Protein Deleted: The Next Frontier in Precision Medicine and IP Strategy
As we previously discussed, beginning in 2022, a series of patent infringement lawsuits were filed against Moderna and collaborators
Continue Reading mRNA/LNP Patent Litigation Update (Q1 2025)
In 1910, German scientist Paul Ehrlich introduced a groundbreaking concept to the world: chemical compounds could be engineered to interact
Continue Reading Key Patent Considerations for Antibody Drug Conjugates (ADCs)
Co-authored by Sheena Wang and Ellie Purnell of HGF limited, “CRISPR and Agriculture” was originally published by Food and Drink
Continue Reading CRISPR and Agriculture
Our current food system is facing a myriad of critical challenges. The United Nations predicts that the world population will
Continue Reading The Future of Food: Regulatory and Patent Landscape of Genome Editing in Food Technology
The Unted States Patent and Trademark Office (USPTO) recently published new guidance on subject-matter eligibility as related to Artificial Intelligence
Continue Reading This Summer in Artificial Intelligence: Newly Released USPTO Guidance and Exemplary Worldwide Inventorship Updates